RHEUMATOID ARTHRITIS AS A RISK FACTOR FOR THE DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE
DOI:
https://doi.org/10.30890/2567-5273.2024-32-00-081Ключові слова:
rheumatoid arthritis, non-alcoholic fatty liver diseaseАнотація
Rheumatoid arthritis (RA) is one of the most common systemic autoimmune diseases with the development of chronic inflammation. Autoimmune processes in RA and the influence of drugs can cause the development of non-alcoholic fatty liver disease (NAFLD). ThMetrics
Посилання
McInnes, I. B., & Schett, G. (2011). The pathogenesis of rheumatoid arthritis. The New England journal of medicine, 365(23), 2205–2219. https://doi.org/10.1056/NEJMra1004965
Firestein G. S. (2003). Evolving concepts of rheumatoid arthritis. Nature, 423(6937), 356–361. https://doi.org/10.1038/nature01661
Wasserman A. (2018). Rheumatoid Arthritis: Common Questions About Diagnosis and Management. American family physician, 97(7), 455–462.
Assayag, D., Lee, J. S., & King, T. E., Jr (2014). Rheumatoid arthritis associated interstitial lung disease: a review. Medicina, 74(2), 158–165.
England, B. R., Thiele, G. M., Anderson, D. R., & Mikuls, T. R. (2018). Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ (Clinical research ed.), 361, k1036. https://doi.org/10.1136/bmj.k1036
Radovanović-Dinić, B., Tešić-Rajković, S., Zivkovic, V., & Grgov, S. (2018). Clinical connection between rheumatoid arthritis and liver damage. Rheumatology international, 38(5), 715–724. https://doi.org/10.1007/s00296-018-4021-5
Wendt, M. M. N., de Oliveira, M. C., Franco-Salla, G. B., Castro, L. S., Parizotto, Â. V., Souza Silva, F. M., Natali, M. R. M., Bersani-Amado, C. A., Bracht, A., & Comar, J. F. (2019). Fatty acids uptake and oxidation are increased in the liver of rats with adjuvant-induced arthritis. Biochimica et biophysica acta. Molecular basis of disease, 1865(3), 696–707. https://doi.org/10.1016/j.bbadis.2018.12.019
Zhou, D., & Fan, J. G. (2019). Microbial metabolites in non-alcoholic fatty liver disease. World journal of gastroenterology, 25(17), 2019–2028. https://doi.org/10.3748/wjg.v25.i17.2019
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018). Mechanisms of NAFLD development and therapeutic strategies. Nature medicine, 24(7), 908–922. https://doi.org/10.1038/s41591-018-0104-9
Vassiliadis, E., Oliveira, C. P., Alvares-da-Silva, M. R., Zhang, C., Carrilho, F. J., Stefano, J. T., Rabelo, F., Pereira, L., Kappel, C. R., Henriksen, K., Veidal, S. S., Vainer, B., Duffin, K. L., Christiansen, C., Leeming, D. J., & Karsdal, M. (2012). Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. American journal of translational research, 4(4), 403–414.
Aithal G. P. (2011). Hepatotoxicity related to antirheumatic drugs. Nature reviews. Rheumatology, 7(3), 139–150. https://doi.org/10.1038/nrrheum.2010.214
Younossi Z. M. (2019). Non-alcoholic fatty liver disease - A global public health perspective. Journal of hepatology, 70(3), 531–544. https://doi.org/10.1016/j.jhep.2018.10.033
Vernon, G., Baranova, A., & Younossi, Z. M. (2011). Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary pharmacology & therapeutics, 34(3), 274–285. https://doi.org/10.1111/j.1365-2036.2011.04724.x
Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2016). Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism: clinical and experimental, 65(8), 1109–1123. https://doi.org/10.1016/j.metabol.2016.05.003
Eslam, M., Valenti, L., & Romeo, S. (2018). Genetics and epigenetics of NAFLD and NASH: Clinical impact. Journal of hepatology, 68(2), 268–279. https://doi.org/10.1016/j.jhep.2017.09.003
Chiba, T., Noji, K., Shinozaki, S., Suzuki, S., Umegaki, K., & Shimokado, K. (2016). Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P450 genes in a mouse model. The Journal of pharmacy and pharmacology, 68(12), 1567–1576. https://doi.org/10.1111/jphp.12646
Lertnawapan, R., Chonprasertsuk, S., & Siramolpiwat, S. (2019). Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate. International journal of rheumatic diseases, 22(2), 214–221. https://doi.org/10.1111/1756-185X.13442
Kobayashi, H., Watanabe, H., & Ohira, H. (2016). Nihon rinsho. Japanese journal of clinical medicine, 74(6), 1007–1011.
Tardito, S., Martinelli, G., Soldano, S., Paolino, S., Pacini, G., Patane, M., Alessandri, E., Smith, V., & Cutolo, M. (2019). Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. Autoimmunity reviews, 18(11), 102397. https://doi.org/10.1016/j.autrev.2019.102397
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2024 Автори
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
